Enhanced immunogenicity of HIV-1 envelope gp140 proteins fused to APRIL. by Gözde Isik, Kwinten Sliepen, Thijs van Montfort, Rogier W Sanders

Get full text

Two HIV-1 variants resistant to small molecule CCR5 inhibitors differ in how they use CCR5 for entry. by Reem Berro, Rogier W Sanders, Min Lu, Per J Klasse, John P Moore

Get full text

Comparison of blood and lymph node cells after intramuscular injection with HIV envelope immunogens by Suzanne Day, Charandeep Kaur, Hannah M. Cheeseman, Emily de Groot, Emily de Groot, Leon R. McFarlane, Maniola Tanaka, Sofia Coelho, Tom Cole, Nana-Marie Lemm, Nana-Marie Lemm, Adrian Lim, Rogier W. Sanders, Rogier W. Sanders, Rogier W. Sanders, Becca Asquith, Robin J. Shattock, Katrina M. Pollock, Katrina M. Pollock

Get full text

Engineering and Characterization of a Fluorescent Native-Like HIV-1 Envelope Glycoprotein Trimer by Kwinten Sliepen, Thijs van Montfort, Gabriel Ozorowski, Laura K. Pritchard, Max Crispin, Andrew B. Ward, Rogier W. Sanders

Get full text

Capturing the inherent structural dynamics of the HIV-1 envelope glycoprotein fusion peptide by Sonu Kumar, Anita Sarkar, Pavel Pugach, Rogier W. Sanders, John P. Moore, Andrew B. Ward, Ian A. Wilson

Get full text

Dendritic cell-induced activation of latent HIV-1 provirus in actively proliferating primary T lymphocytes. by Renée M van der Sluis, Thijs van Montfort, Georgios Pollakis, Rogier W Sanders, Dave Speijer, Ben Berkhout, Rienk E Jeeninga

Get full text

Anti-HIV-1 Nanobody-IgG1 Constructs With Improved Neutralization Potency and the Ability to Mediate Fc Effector Functions by Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Rogier W. Sanders, Theo Verrips, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils

Get full text

Corrigendum: Anti-HIV-1 nanobody-IgG1 constructs with improved neutralization potency and the ability to mediate Fc effector functions by Angela I. Schriek, Marlies M. van Haaren, Meliawati Poniman, Gillian Dekkers, Arthur E. H. Bentlage, Marloes Grobben, Gestur Vidarsson, Rogier W. Sanders, Rogier W. Sanders, Theo Verrips, Theo Verrips, Teunis B. H. Geijtenbeek, Raimond Heukers, Neeltje A. Kootstra, Steven W. de Taeye, Marit J. van Gils

Get full text

The Envelope-Based Fusion Antigen GP120C14K Forming Hexamer-Like Structures Triggers T Cell and Neutralizing Antibody Responses Against HIV-1 by Suresh C. Raman, Ernesto Mejías-Pérez, Carmen E. Gomez, Juan García-Arriaza, Beatriz Perdiguero, Aneesh Vijayan, Mar Pérez-Ruiz, Ana Cuervo, César Santiago, Carlos Oscar S. Sorzano, Cristina Sánchez-Corzo, Christiane Moog, Judith A. Burger, Anna Schorcht, Rogier W. Sanders, Rogier W. Sanders, José L. Carrascosa, Mariano Esteban

Get full text

HIV-1 envelope glycoprotein resistance to monoclonal antibody 2G12 is subject-specific and context-dependent in macaques and humans. by Delphine C Malherbe, Rogier W Sanders, Marit J van Gils, Byung Park, Michelle M Gomes, Hanneke Schuitemaker, Susan Barnett, Nancy L Haigwood

Get full text

An HIV-1 envelope glycoprotein trimer with an embedded IL-21 domain activates human B cells. by Gözde Isik, Nancy P Y Chung, Thijs van Montfort, Sergey Menis, Katie Matthews, William R Schief, John P Moore, Rogier W Sanders

Get full text

HIV-1 autologous antibody neutralization associates with mother to child transmission. by Elly Baan, Anthony de Ronde, Martijn Stax, Rogier W Sanders, Stanley Luchters, Joseph Vyankandondera, Joep M Lange, Georgios Pollakis, William A Paxton

Get full text

Influenza A Virus Hemagglutinin Trimer, Head and Stem Proteins Identify and Quantify Different Hemagglutinin-Specific B Cell Subsets in Humans by Aafke Aartse, Dirk Eggink, Mathieu Claireaux, Sarah van Leeuwen, Petra Mooij, Willy M. Bogers, Rogier W. Sanders, Gerrit Koopman, Marit J. van Gils

Get full text

Optimized Hepatitis C Virus (HCV) E2 Glycoproteins and their Immunogenicity in Combination with MVA-HCV by María Q. Marín, Kwinten Sliepen, Juan García-Arriaza, Sylvie M. Koekkoek, Patricia Pérez, Carlos Óscar S. Sorzano, Carmen E. Gómez, Rogier W. Sanders, Mariano Esteban

Get full text

Clinical adjuvant combinations stimulate potent B-cell responses in vitro by activating dermal dendritic cells. by Katie Matthews, Nancy P Y Chung, Per Johan Klasse, Magda Moutaftsi, Darrick Carter, André M Salazar, Steven G Reed, Rogier W Sanders, John P Moore

Get full text

Signatures of V H 1-69-derived hepatitis C virus neutralizing antibody precursors defined by binding to envelope glycoproteins by Joan Capella-Pujol, Marlon de Gast, Laura Radić, Ian Zon, Ana Chumbe, Sylvie Koekkoek, Wouter Olijhoek, Janke Schinkel, Marit J. van Gils, Rogier W. Sanders, Kwinten Sliepen

Get full text

Lower Broadly Neutralizing Antibody Responses in Female Versus Male HIV-1 Infected Injecting Drug Users by Zelda EULER, Tom L. VAN DEN KERKHOF, Roger D. KOUYOS, Damien C. TULLY, Todd M. ALLEN, Alexandra TRKOLA, Rogier W. SANDERS, Hanneke SCHUITEMAKER, Marit J. VAN GILS

Get full text

Structure and topology around the cleavage site regulate post-translational cleavage of the HIV-1 gp160 signal peptide by Erik Lee Snapp, Nicholas McCaul, Matthias Quandte, Zuzana Cabartova, Ilja Bontjer, Carolina Källgren, IngMarie Nilsson, Aafke Land, Gunnar von Heijne, Rogier W Sanders, Ineke Braakman

Get full text

Similarities and differences between native HIV-1 envelope glycoprotein trimers and stabilized soluble trimer mimetics. by Alba Torrents de la Peña, Kimmo Rantalainen, Christopher A Cottrell, Joel D Allen, Marit J van Gils, Jonathan L Torres, Max Crispin, Rogier W Sanders, Andrew B Ward

Get full text

Structural dynamics reveal isolate-specific differences at neutralization epitopes on HIV Env by Edgar A. Hodge, Gajendra S. Naika, Sally M. Kephart, Adam Nguyen, Richard Zhu, Mark A. Benhaim, Wenjin Guo, John P. Moore, Shiu-Lok Hu, Rogier W. Sanders, Kelly K. Lee

Get full text